Pages that link to "Q47303680"
Jump to navigation
Jump to search
The following pages link to G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete engraftment after allogeneic hematopoietic transplantation. (Q47303680):
Displaying 5 items.
- Isolation of highly suppressive CD25 FoxP3 T regulatory cells from G-CSF-mobilized donors with retention of cytotoxic anti-viral CTLs: application for multi-functional immunotherapy post stem cell transplantation (Q37490823) (← links)
- Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective (Q38349208) (← links)
- New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT. (Q38643400) (← links)
- Immunotherapy following relapse of acute leukaemia after T-cell-replete allogeneic peripheral blood progenitor cell transplantation: importance of new onset chronic graft-versus-host disease (Q44325600) (← links)
- Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prosp (Q51089741) (← links)